Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0LF5B
|
||||
Former ID |
DIB015572
|
||||
Drug Name |
KN-38-7271
|
||||
Synonyms |
Cannabinoid 1/2 receptor agonists (cerebrovascular ischemia/pain), Bayer; Cannabinoid 1/2 receptor agonists (traumatic brain injury/stroke), KeyNeurotek
|
||||
Indication | Ischemia [ICD9: 459.89; ICD10:I99.8] | Discontinued in Phase 2 | [547265] | ||
Company |
Bayer AG
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
O=S(=O)(Oc1cccc(c1)Oc1cccc2C[C@H](Cc12)CO)CCCC(F)(F)F
|
||||
CAS Number |
CAS 212188-60-8
|
||||
Target and Pathway | |||||
Target(s) | Cannabinoid receptor 2 | Target Info | Modulator | ||
Cannabinoid receptor 1 | Target Info | Modulator | |||
PANTHER Pathway | Endogenous cannabinoid signaling | ||||
Pathway Interaction Database | N-cadherin signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.